You are here
No longer requiring certification in general surgery prior to certification in vascular surgery created several training pathways.
The oft-quoted G.K. Chesterton said that the “fatal metaphor of progress, which means leaving things behind us, has utterly obscured the real idea of growth, which means leaving things inside us.” Today is my final day at Cardiovascular Business, where I am grateful to have worked and grown for the past seven years.
Given the fallout from ACC.13, where the PREVAIL study was pulled from the late-breaking lineup because the trial sponsor released the data before the embargo lift, many have continued to question the embargo process, especially due to the increasing frequency of such events. Cardiovascular Business spoke with Ajay J. Kirtane, MD, about this controversial topic.
Noncentral peripherally inserted central venous catheter (PICC) tip locations, younger age and exposure to the intensive care unit were independent risk factors for complications that necessitated PICC removal. So found a large pediatric study published March 19 in JAMA Pediatrics.
Younger patients have not experienced comparable declines in heart failure (HF) hospital stay, length of stay and in-hospital mortality as older patients, and black men remain a vulnerable population for HF hospital stay, according to a study published March 12 in the Journal of the American College of Cardiology.
SAN FRANCISCO—Off-pump surgery in high-risk patients is associated with a lower incidence of serious complications, and is a safer way of direct revascularization in these patients, according to the late-breaking PRAGUE-6 trial, presented March 11 at the American College of Cardiology (ACC) scientific session.
SAN FRANCISCO—In patients 75 years of age or older, there was no significant difference between on-pump and off-pump CABG in the composite outcome of death, stroke, MI, repeat revascularization or new renal-replacement therapy within 30 days and within one year after surgery, according to the late-breaking GOPCABE trial, presented March 11 at the American College of Cardiology (ACC) scientific session.
SAN FRANCISCO—ORBIT-AF is a prospective, longitudinal, observational study that evaluated treatment patterns and the subsequent outcomes of 10,000 patients in the U.S. As part of the analysis, Jonathan P. Piccini, MD, and his colleagues looked at potential gender disparities in the treatment and clinical outcomes of these patients. The results were presented at the American College of Cardiology (ACC) scientific session.
SAN FRANCISCO—Measurement of left ventricular ejection fraction (LVEF) in hospitalized heart failure patients varies, with patients outside of hospitals with tertiary services at a disadvantage, according to a scientific poster presented March 10 at the American College of Cardiology (ACC) scientific session.
SAN FRANCISCO—All-cause and cardiovascular mortality were similar for transcatheter aortic valve replacement (TAVR) compared with open-heart surgery in high-risk older patients at three years with no increased risk of stroke after 30 days, according to three-year data from the PARTNER study presented March 11 at the American College of Cardiology’s (ACC) scientific session.